---
title: Anticoagulants
author: Corbin Cox
layout: diseases
last-updated: 2019-01-02
created: 2019-01-02
toc: true
common: true
---

# Warfarin[^lexi]

## Dosing

* [Warfarin Dosing Calculator](http://www.warfarindosing.org/Source/Home.aspx)
* Typically initiate at 5mg QD and adjust, consider 7.5mg QD or 2.5mg QD in special populations
  * 2.5mg
    * Elderly
    * Renal impairment
    * FHx of warfarin sensitivity
  * 7.5mg
    * Significant obesity
    * FHx of high warfarin doses
* 3mo of treatment
  * Bioprosthetic mitral valve
  * Provoked PE / DVT (no cancer)
  * MI induced LV thrombus
* Indefinite Treatment
  * A-fib
  * Mechanical Valves
  * Unprovoked PE / DVT
* Bridge until therapeutic INR for 24hr with **therapeutic** parenteral anticoagulant (usually enoxaparin)
* Adjust based on CYP2C9 and VKOR1 genotype, not usually relevant

## Drug Interactions

Metabolized predominantly by CYP2C9, but also CYP1A2, 2C19, and 3A4.

## Antidote[^lexi]<sup>, </sup>[^tintinalli]

* Elevated INR w/ Serious or Life-Threatening Bleed
  * Vit K 5-10mg slow IV bolus
    * Dilute in 50mL and infuse over 20min,  or give no faster than 1mg/min
  * 4-factor PCC
    * INR &gt; 6: 50 U/kg NTE 5000 U
    * INR 4-6: 35 U/kg NTE 3500 U
    * INR &lt; 4: 25 U/kg NTE 2500 U
* INR &gt; 10 w/o significant bleeding
  * Hold 1-2 doses
  * Vit K 2-2.5mg PO
  * Hold more and repeat Vit K as appropriate
* INR 4.5-10 w/o significant bleeding
  * Hold 1-2 doses
  * If high risk for bleeding, give Vit K 1-2mg PO
  * Monitor closely
* INR &lt; 4.5
  * Lower dose or hold 1 dose

# DOACs

| Indication                 | Dose                                                         | Renal Adjustments                                            | Notes              |
| -------------------------- | ------------------------------------------------------------ | ------------------------------------------------------------ | ------------------ |
| Apixaban                   |                                                              |                                                              |                    |
| Non-Valvular A-fib         | 5mg BID                                                      | 2.5mg BID if pt has 2 of the following<br />&ge; 80yo<br />SCr &ge; 1.5<br />&le; 60kg | No bridge required |
| DVT / PE Treatment         | 10mg PO BID x7d, then 5mg BID                                |                                                              | No bridge required |
| Indefinite DVT Prophylaxis | 2.5mg PO BID                                                 |                                                              | No bridge required |
| THA / TKA DVT Prophylaxis  | 2.5mg PO BID, starting 12-24htr after surgery x10-14d (TKA) or x30d (THA) |                                                              | No bridge required |
| Rivaroxaban                |                                                              |                                                              |                    |
| Edoxaban                   |                                                              |                                                              |                    |
| Dabigatran                 |                                                              |                                                              |                    |



# Parenteral





# References

{% include sources.md %}